Leqembi, based on the active ingredient lecanemab, is already approved as an injection treatment in the US, while the drug is also approved in several countries as an intravenous treatment.
发布者：BY Christopher Karlsson，转转请注明出处：https://robotalks.cn/eisai-and-biogen-apply-for-new-variant-of-alzheimers-drug-in-japan/
BRISBANE, Australia–( ORGANIZATION CORD)– Megaport Limited (ASX: MP1) (” Megaport”), el proveedor líder mundial de redes como servicio (NaaS), anuncia su ex…
Micropolis, a designer of unmanned ground automobiles and AI-driven protection options, has actually started the screening stage of its cooperation with SEE Holding at The Lasting …
Integrity and long life issues might when have actually been amongst one of the most typical factors for denying an electrical automobile. A brand-new research study released in Na…
In sub-Saharan Africa, high levels of particulate matter (PM2.5) pollution from vehicle tailpipe emissions cause poor health, developmental stunting, and even death. Vehicle emissi…
